Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.
Plus, advocates in Canada want health officials there to also allow more gay and bi men to donate blood.
In the United States, an FDA expert advisory panel voted on December 10 to recommend emergency use authorization.
The 90-90-90 HIV targets expire at the end of 2020. Bob Leahy looks at what comes next and what role people living with HIV can play.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
Intergenerational learning is vital. Here are six ideas I hope to convey during an upcoming youth HIV leadership conference.
The need for HIV self-testing has increased amid the COVID-19 pandemic.
Hint: It starts with three letters.
You’ve heard about the 90-90-90 HIV targets. But what about measuring quality of life? Bob Leahy wonders about adding a fourth 90.
As overdose death rates have risen in this population, life expectancy has increasingly narrowed.
Plus: Watch a video interview series exploring the intersections between HIV and COVID-19.
Survey says Canadian PLWHIV have often been struggling—but they are resilient
How a Canadian living with HIV has coped with being a shut-in, and what he has learned about himself—and about us
Here’s a consistent message for guys looking to hook up: “Just say no.”
A Canadian hospital lab adapts two Roche diagnostic systems, allowing for over 2,000 COVID-19 tests a day. How many are in the U.S.?
The FDA recently held up the U.S. approval based on concerns over the monthly injectable regimen’s manufacturing.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.